These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 32164084)

  • 1. [Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia].
    Zhao JP; Hu Y; Du RH; Chen ZS; Jin Y; Zhou M; Zhang J; Qu JM; Cao B
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Mar; 43(3):183-184. PubMed ID: 32164084
    [No Abstract]   [Full Text] [Related]  

  • 2. On the use of corticosteroids for 2019-nCoV pneumonia.
    Shang L; Zhao J; Hu Y; Du R; Cao B
    Lancet; 2020 Feb; 395(10225):683-684. PubMed ID: 32122468
    [No Abstract]   [Full Text] [Related]  

  • 3. Audio Interview: Dexamethasone and Covid-19.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Jul; 383(4):e52. PubMed ID: 32706553
    [No Abstract]   [Full Text] [Related]  

  • 4. The ten reasons why corticosteroid therapy reduces mortality in severe COVID-19.
    Arabi YM; Chrousos GP; Meduri GU
    Intensive Care Med; 2020 Nov; 46(11):2067-2070. PubMed ID: 33026460
    [No Abstract]   [Full Text] [Related]  

  • 5. Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs.
    Georgiev T
    Rheumatol Int; 2020 May; 40(5):825-826. PubMed ID: 32232552
    [No Abstract]   [Full Text] [Related]  

  • 6. Prescribing COVID-19 treatments: what we should never forget.
    Tunesi S; Bourgarit A
    J Infect; 2020 Aug; 81(2):e85. PubMed ID: 32405110
    [No Abstract]   [Full Text] [Related]  

  • 7. [Not Available].
    Kan B; Ahl M; Blennow O; Eriksson P; Nowak P; Parke Å; Stojanovic B; Tovatt T; Vesterbacka J
    Lakartidningen; 2020 Oct; 117():. PubMed ID: 33021326
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhaled corticosteroids in virus pandemics: a treatment for COVID-19?
    Nicolau DV; Bafadhel M
    Lancet Respir Med; 2020 Sep; 8(9):846-847. PubMed ID: 32738928
    [No Abstract]   [Full Text] [Related]  

  • 9. WHO recommends corticosteroids for patients with severe or critical COVID-19.
    Keyt H
    Ann Intern Med; 2021 Jan; 174(1):JC2. PubMed ID: 33395337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury.
    Russell CD; Millar JE; Baillie JK
    Lancet; 2020 Feb; 395(10223):473-475. PubMed ID: 32043983
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective.
    Halpin DMG; Singh D; Hadfield RM
    Eur Respir J; 2020 May; 55(5):. PubMed ID: 32341100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How likely are COVID-19 interventions to benefit the sickest patients?
    Perner A; Tirupakuzhi Vijayaraghavan BK; Venkatesh B
    Intensive Care Med; 2020 Jul; 46(7):1441-1444. PubMed ID: 32519004
    [No Abstract]   [Full Text] [Related]  

  • 13. Migratory Pulmonary Infiltrates in a Patient With COVID-19 Infection and the Role of Corticosteroids.
    John TM; Malek AE; Mulanovich VE; Adachi JA; Raad II; Hamilton AR; Shpall EJ; Rezvani K; Aitken SL; Jain N; Klein K; Martinez F; Jacob CN; Cherian SV; Manzano JM; Muthu M; Wegner R
    Mayo Clin Proc; 2020 Sep; 95(9):2038-2040. PubMed ID: 32861345
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of coronavirus disease 2019.
    Hung IFN
    Curr Opin HIV AIDS; 2020 Nov; 15(6):336-340. PubMed ID: 33002954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia.
    Zhou W; Liu Y; Tian D; Wang C; Wang S; Cheng J; Hu M; Fang M; Gao Y
    Signal Transduct Target Ther; 2020 Feb; 5(1):18. PubMed ID: 32296012
    [No Abstract]   [Full Text] [Related]  

  • 16. Lessons from the Italian COVID-19 frontline.
    Bellan M; Sainaghi PP; Gavelli F; Patrucco F; Avanzi GC; Pirisi M; Castello LM
    Minerva Med; 2020 Aug; 111(4):303-305. PubMed ID: 33032392
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis.
    Li H; Chen C; Hu F; Wang J; Zhao Q; Gale RP; Liang Y
    Leukemia; 2020 Jun; 34(6):1503-1511. PubMed ID: 32372026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis.
    Armstrong-James D; Youngs J; Bicanic T; Abdolrasouli A; Denning DW; Johnson E; Mehra V; Pagliuca T; Patel B; Rhodes J; Schelenz S; Shah A; van de Veerdonk FL; Verweij PE; White PL; Fisher MC
    Eur Respir J; 2020 Oct; 56(4):. PubMed ID: 32703771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy.
    Saini KS; Lanza C; Romano M; de Azambuja E; Cortes J; de Las Heras B; de Castro J; Lamba Saini M; Loibl S; Curigliano G; Twelves C; Leone M; Patnaik MM
    Br J Cancer; 2020 Sep; 123(5):694-697. PubMed ID: 32572174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baricitinib as potential treatment for 2019-nCoV acute respiratory disease.
    Richardson P; Griffin I; Tucker C; Smith D; Oechsle O; Phelan A; Rawling M; Savory E; Stebbing J
    Lancet; 2020 Feb; 395(10223):e30-e31. PubMed ID: 32032529
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.